Home » Stocks » DRIO

DarioHealth Corp. (DRIO)

Stock Price: $14.89 USD 0.18 (1.22%)
Updated Jul 29, 2021 11:55 AM EDT - Market open
Market Cap 247.12M
Revenue (ttm) 9.50M
Net Income (ttm) -37.45M
Shares Out 16.44M
EPS (ttm) -4.31
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day July 29
Last Price $14.89
Previous Close $14.71
Change ($) 0.18
Change (%) 1.22%
Day's Open 14.90
Day's Range 14.45 - 15.00
Day's Volume 42,174
52-Week Range 7.26 - 31.85

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

NEW YORK, July 27, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a pioneer in the global digital therapeutics market, today announced the launch of its digital behavioral health solution that n...

2 days ago - PRNewsWire

NEW YORK, July 20, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as a digital health provider by Alabam...

1 week ago - PRNewsWire

NEW YORK , July 13, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced Chief Medical Officer Omar Manejwala, M.D. will present "Re...

2 weeks ago - PRNewsWire

NEW YORK, July 12, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced the launch of three new employer client contracts, inc...

2 weeks ago - PRNewsWire

NEW YORK, June 29, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, presented new clinical research today at the American Diabetes Associa...

1 month ago - PRNewsWire

NEW YORK, June 24, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has been selected as digital health provider by Coastal ...

1 month ago - PRNewsWire

NEW YORK, June 16, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today the launch of the Upright GO S, a new wearable sensor ...

1 month ago - PRNewsWire

NEW YORK, June 15, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it is set to join the broad-market Russell 3000® Index and ...

1 month ago - PRNewsWire

NEW YORK, June 8, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, today announced the consummation of the previously announced acquisiti...

1 month ago - PRNewsWire

Study results to be presented at the 14th International Conference on Advanced Technologies and Treatments for Diabetes NEW YORK, June 4, 2021 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader ...

1 month ago - PRNewsWire

NEW YORK, June 3, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the company plans to participate in the upcoming ...

1 month ago - PRNewsWire

NEW YORK,, May 27, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced the publication of a new study through a Letter to the Edit...

2 months ago - PRNewsWire

NEW YORK, May 26, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that management will participate in the 18th Annual Craig-Ha...

2 months ago - PRNewsWire

DarioHealth Corp (NASDAQ: DRIO) has agreed to acquire PsyInnovations Inc (dba wayForward), a behavioral health digital platform, for $30 million. wayForward is currently providing its full suite of digi...

2 months ago - Benzinga

NEW YORK, May 18, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it has entered into an agreement to acquire PsyInnovations, ...

2 months ago - PRNewsWire

NEW YORK, May 17, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the first quarter of 2021 and provided ...

2 months ago - PRNewsWire

DarioHealth (NASDAQ:DRIO) announces its next round of earnings this Monday, May 17. Here is Benzinga's everything-that-matters guide for this Monday's Q1 earnings announcement.

2 months ago - Benzinga

NEW YORK, May 10, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the first quarter...

2 months ago - PRNewsWire

NEW YORK, April 20, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced today the launch of a new virtual care initiative with MediOrbis...

3 months ago - PRNewsWire

NEW YORK, March 9, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the fourth quarter and full year 2020 ...

4 months ago - PRNewsWire

DarioHealth (NASDAQ:DRIO) releases its next round of earnings this Tuesday, March 09. Here is Benzinga's essential guide to DarioHealth's Q4 earnings report.

4 months ago - Benzinga

NEW YORK, March 1, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced it would release its financial results for the fourth quart...

4 months ago - PRNewsWire

NEW YORK, Feb. 19, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that Erez Raphael, Chief Executive Officer, is schedu...

5 months ago - PRNewsWire

NEW YORK, Jan. 27, 2021 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today the signing of a definitive agreement to acquire digi...

6 months ago - PRNewsWire

NEW YORK--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”) announces its investigation on behalf of DarioHealth Corp. (Nasdaq: DRIO) concerning the Company and its directors' and officers' possible ...

6 months ago - Business Wire

NEW YORK, Dec. 22, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics (DTx) market, announced today that the Company has entered into an agreement to pro...

7 months ago - PRNewsWire

DarioHealth Corp. (DRIO) CEO Erez Raphael on Q3 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

NEW YORK, Nov. 12, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today reported financial results for the third quarter 2020 and provided a ...

8 months ago - PRNewsWire

DRIO offers a diabetes management solution that is highly rated, provides strong ROI for all parties, and simpler than main competitor Livongo. Seasoned executives in the digital therapeutics space have...

9 months ago - Seeking Alpha

NEW YORK, Oct. 13, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, announced that Vitality Group has chosen the company's digital therapeutics...

9 months ago - PRNewsWire

DarioHealth Corp. (DRIO) CEO Erez Raphael on Q2 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Shares of DarioHealth (NASDAQ:DRIO) moved higher by 2% in pre-market trading after the company reported Q2 results.

11 months ago - Benzinga

NEW YORK, Aug. 12, 2020 /PRNewswire/ -- DarioHealth Corp.

11 months ago - PRNewsWire

NEW YORK, July 31, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that it closed a private placement transaction with accredi...

11 months ago - PRNewsWire

NEW YORK, June 11, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a pioneer in the global digital therapeutics market, today announced that the company has signed its first two remote patient mo...

1 year ago - PRNewsWire

DarioHealth Corp. (DRIO) CEO Erez Raphael on Q1 2020 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Shares of DarioHealth (NASDAQ:DRIO) remained unaffected at $7.95 after the company reported Q1 results.

1 year ago - Benzinga

DarioHealth Corp. (DRIO) CEO Erez Raphael on Q4 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

Shares of digital health company DarioHealth Corp (NASDAQ: DRIO) are advancing strongly Tuesday.

1 year ago - Benzinga

Shares of DarioHealth Corp. DRIO, +23.40% jumped 103% as it announced that Walmart would sell DarioHealth's digital diabetes management system online.

1 year ago - Market Watch

DarioHealth Corp. (DRIO) CEO Erez Raphael on Q3 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

DarioHealth's (DRIO) CEO Erez Raphael on Q2 2019 Results - Earnings Call Transcript

1 year ago - Seeking Alpha

DarioHealth's (DRIO) CEO Erez Raphael on Q1 2019 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

DarioHealth Corp. (DRIO) CEO Erez Raphael on Q4 2018 Results - Earnings Call Transcript

2 years ago - Seeking Alpha

About DRIO

DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario Tools, which are devices that integrate with applications on a user's smartphone; DarioEngage, a population health management platform; and the Dario Loop, an AI-driven journey engine. It also sells device-specific disposables test strip cartridges, lancets, and Dario Blood Glucose Monitoring System; and Dario Smart Diabetes Management Solution, which includes tools to help diabetic ... [Read more...]

Industry
Diagnostics & Research
Founded
2011
Stock Exchange
NASDAQ
Ticker Symbol
DRIO
Full Company Profile

Financial Performance

In 2020, DarioHealth's revenue was $7.58 million, an increase of 0.22% compared to the previous year's $7.56 million. Losses were -$29.45 million, 66.0% more than in 2019.

Financial Statements

Analyst Forecasts

According to 4 analysts, the average rating for DarioHealth stock is "Strong Buy." The 12-month stock price forecast is 27.86, which is an increase of 87.11% from the latest price.

Price Target
$27.86
(87.11% upside)
Analyst Consensus: Strong Buy